Open access
753
Views
1
CrossRef citations to date
0
Altmetric
Articles
Shrunken pore syndrome in childhood cancer survivors treated with potentially nephrotoxic therapy
Esmee C. M. Kooijmansa Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Amsterdam, The Netherlands;b Princess Máxima Center for Pediatric Oncology, Utrecht, The NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0001-6961-1684View further author information
, https://orcid.org/0000-0001-6961-1684View further author information
Helena J. H. van der Palb Princess Máxima Center for Pediatric Oncology, Utrecht, The NetherlandsView further author information
, Maxime C. F. Pilona Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Amsterdam, The NetherlandsView further author information
, Saskia M. F. Pluijmb Princess Máxima Center for Pediatric Oncology, Utrecht, The NetherlandsView further author information
, Margriet van der Heiden-van der Loob Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;c Dutch Childhood Oncology Group, Utrecht, The NetherlandsView further author information
, Leontien C. M. Kremerb Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;d Division of Child health, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands;e Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, Pediatric Oncology, Amsterdam, The NetherlandsView further author information
, Dorine Brestersb Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;f Willem Alexander Children’s Hospital/Leiden University Medical Center, Leiden, The NetherlandsView further author information
, Eline van Dulmen-den Broedera Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Amsterdam, The NetherlandsView further author information
, Marry M. van den Heuvel-Eibrinkb Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;d Division of Child health, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands;g Department of Pediatric Oncology, Sophia Children’s Hospital/Erasmus Medical Center, Rotterdam, The NetherlandsView further author information
, Jacqueline J. Loonenh Department of Hematology, Radboud University Medical Center, Nijmegen, The NetherlandsView further author information
, Marloes Louwerensi Department of Internal Medicine, Leiden University Medical Center, Leiden, The NetherlandsView further author information
, Sebastian J. C. Neggersj Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The NetherlandsView further author information
, Hanneke M. van Santenk Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The NetherlandsView further author information
, Wim J. E. Tissingb Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;l Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, The NetherlandsView further author information
, Andrica C. H. de Vriesb Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;g Department of Pediatric Oncology, Sophia Children’s Hospital/Erasmus Medical Center, Rotterdam, The NetherlandsView further author information
, Gertjan J. L. Kaspersa Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Amsterdam, The Netherlands;b Princess Máxima Center for Pediatric Oncology, Utrecht, The NetherlandsView further author information
, Margreet A. Veeninga Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Amsterdam, The Netherlands;b Princess Máxima Center for Pediatric Oncology, Utrecht, The NetherlandsView further author information
, Arend Bökenkampm Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Nephrology, Amsterdam, The NetherlandsView further author information
& on behalf of the Dutch LATER study group show all
Pages 541-548
|
Received 14 Jul 2022, Accepted 25 Sep 2022, Published online: 06 Oct 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.